Citadel Advisors - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 41 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,086,000
-1.9%
4,000,0000.0%0.00%0.0%
Q3 2019$3,145,000
-8.3%
4,000,0000.0%0.00%
-50.0%
Q2 2019$3,430,000
-71.9%
4,000,000
-70.9%
0.00%
-66.7%
Q1 2019$12,188,000
-55.6%
13,750,000
-58.0%
0.01%
-60.0%
Q4 2018$27,466,000
+43.5%
32,750,000
+45.6%
0.02%
+66.7%
Q3 2018$19,145,000
+1.4%
22,500,000
+15.4%
0.01%0.0%
Q2 2018$18,885,000
-30.0%
19,500,000
-33.9%
0.01%
-40.0%
Q1 2018$26,988,000
+5.4%
29,500,000
-1.7%
0.02%
-6.2%
Q4 2017$25,603,000
+41.8%
30,000,000
+50.0%
0.02%
+14.3%
Q3 2017$18,060,000
+29.4%
20,000,000
+23.0%
0.01%
+16.7%
Q2 2017$13,962,000
+162.0%
16,257,000
+159.8%
0.01%
+140.0%
Q1 2017$5,328,000
-48.7%
6,257,000
-54.1%
0.01%
-50.0%
Q4 2016$10,391,000
+15.4%
13,632,000
+23.9%
0.01%
+11.1%
Q3 2016$9,004,000
-24.0%
11,000,000
-18.5%
0.01%
-30.8%
Q2 2016$11,846,000
+32.6%
13,500,000
+35.0%
0.01%
+18.2%
Q1 2016$8,934,00010,000,0000.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 3,586,000$3,237,0002.17%
Telemetry Investments, L.L.C. 4,000,000$3,610,0001.29%
Castle Creek Arbitrage, LLC 6,000,000$5,419,0000.54%
Man Investments (CH) AG 600,000$542,0000.46%
SSI INVESTMENT MANAGEMENT LLC 5,683,000$5,129,0000.44%
CANYON CAPITAL ADVISORS LLC 29,000,000$26,173,0000.39%
PFM Health Sciences, LP 21,362,000$19,386,0000.38%
IRON Financial LLC 500,000$454,0000.35%
Partner Investment Management, L.P. 373,000$338,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 29,555,000$26,667,0000.30%
View complete list of ACORDA THERAPEUTICS INC shareholders